资本眼一周行情 上周（6月15日至21日），医药生物指数下跌1.48%，跑输上证指数2.94个百分点。创新药（BK1106）周内下跌0.90%；恒生医疗保健业指数（HSCICH）周内下跌1.83%；港股创新药ETF广发（513120）周内下跌1.97%。 机构观点 中邮证券 我们探讨高潜力特异性皮炎（AD）市场的下一个方向：口服+新作用机制。银屑病（PsO）治疗市场的规模介于200亿美金~...
Source Link资本眼一周行情 上周（6月15日至21日），医药生物指数下跌1.48%，跑输上证指数2.94个百分点。创新药（BK1106）周内下跌0.90%；恒生医疗保健业指数（HSCICH）周内下跌1.83%；港股创新药ETF广发（513120）周内下跌1.97%。 机构观点 中邮证券 我们探讨高潜力特异性皮炎（AD）市场的下一个方向：口服+新作用机制。银屑病（PsO）治疗市场的规模介于200亿美金~...
Source LinkDisclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.